Carcinogenesis, Vol. 22, No. 12, 1903-1930,
December 2001
© 2001 Oxford University Press
HISTORICAL REVIEW |
Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates
Department of Molecular and Cell Biology and Virus Laboratory, Life Sciences Addition, University of California, Berkeley, CA 94720-3200, USA
Email: hrubin{at}uclink4.berkeley.edu
Abstract
B[a]P (benzo[a]pyrene) has been used as a prototype carcinogenic PAH since its isolation from coal tar in the 1930's. One of its diol epoxides, BPDE-2, is considered its ultimate carcinogen on the basis of its binding to DNA, mutagenicity and extreme pulmonary carcinogenicity in newborn mice. However, BPDE-1 has a similar binding to DNA and mutagenicity but it is not carcinogenic. In addition, BPDE-2 is a weak carcinogen relative to B[a]P when repeatedly applied to mouse skin, the conventional assay site. Its carcinogenicity is increased when applied once as an initiator followed repeatedly by a promoter. This indicates a major role for promotion in carcinogenesis by PAHs. Promotion itself is a 2-stage process, the second of which is selective propagation of the initiated cells. Persistent hyperplasia underlies selection by promoters. The non-carcinogenicity of BPDE-1 has yet to be resolved. PAHs have long been considered the main carcinogens of cigarette smoke but their concentration in the condensate is far too low to account by themselves for the production of skin tumors. The phenolic fraction does however have strong promotional activity when repeatedly applied to initiated mouse skin. Several constituents of cigarette smoke are co-carcinogenic when applied simultaneously with repeated applications of PAHs. Catechol is co-carcinogenic at concentrations found in the condensate. Since cigarette smoking involves protracted exposure to all the smoke constituents, co-carcinogenesis simulates its effects. Both procedures, however, indicate a major role for selection in carcinogenesis by cigarette smoke. That selection may operate on endogenous mutations as well as those induced by PAHs. There are indications that the nicotine-derived NNK which is a specific pulmonary carcinogen in animals contributes to smoking-induced lung cancer in man. Lung adenoma development by inhalation has been induced in mice by the gas phase of cigarette smoke. The role of selection has not been evaluated in either of these cases.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. Rubin Cell-cell contact interactions conditionally determine suppression and selection of the neoplastic phenotype PNAS, April 29, 2008; 105(17): 6215 - 6221. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Ambrosone, S. Kropp, J. Yang, S. Yao, P. G. Shields, and J. Chang-Claude Cigarette Smoking, N-Acetyltransferase 2 Genotypes, and Breast Cancer Risk: Pooled Analysis and Meta-analysis Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 15 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Herceg Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors Mutagenesis, March 1, 2007; 22(2): 91 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jiao, S. L. Allinson, M. J. Walsh, R. Hewitt, K. J. Cole, D. H. Phillips, and F. L. Martin Growth kinetics in MCF-7 cells modulate benzo[a]pyrene-induced CYP1A1 up-regulation Mutagenesis, March 1, 2007; 22(2): 111 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Caino, J. L. Oliva, H. Jiang, T. M. Penning, and M. G. Kazanietz Benzo[a]pyrene-7,8-dihydrodiol Promotes Checkpoint Activation and G2/M Arrest in Human Bronchoalveolar Carcinoma H358 Cells Mol. Pharmacol., March 1, 2007; 71(3): 744 - 750. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Chia, P. A. Newcomb, J. Bigler, L. M. Morimoto, S. N. Thibodeau, and J. D. Potter Risk of Microsatellite-Unstable Colorectal Cancer Is Associated Jointly with Smoking and Nonsteroidal Anti-inflammatory Drug Use. Cancer Res., July 1, 2006; 66(13): 6877 - 6883. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. An, J.-K. Chen, H.-j. Chen, W. Chang, Y.-G. Jiang, Q.-Y. Wei, and X.-M. Chen Characterization of 67 kD Laminin Receptor, a Protein Whose Gene Is Overexpressed on Treatment of Cells with Anti-Benzo[a]pyrene-7,8-Diol-9,10-Epoxide Toxicol. Sci., April 1, 2006; 90(2): 326 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Curtin, M. Hanausek, Z. Walaszek, R. Zoltaszek, J. E. Swauger, A. T. Mosberg, and T. J. Slaga Short-Term Biomarkers of Cigarette Smoke Condensate Tumor Promoting Potential in Mouse Skin Toxicol. Sci., January 1, 2006; 89(1): 66 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Culea, O. Cozar, and E. Culea PAHs in Cigarette Smoke by Gas Chromatography-Mass Spectrometry Indoor and Built Environment, June 1, 2005; 14(3-4): 283 - 292. [Abstract] [PDF] |
||||
![]() |
W. D. Hazelton, M. S. Clements, and S. H. Moolgavkar Multistage Carcinogenesis and Lung Cancer Mortality in Three Cohorts Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1171 - 1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Kim, K. Yamaguchi, S.-H. Lee, P. K. Tithof, G. S. Sayler, J.-H. Yoon, and S. J. Baek Evaluation of Polycyclic Aromatic Hydrocarbons in the Activation of Early Growth Response-1 and Peroxisome Proliferator Activated Receptors Toxicol. Sci., May 1, 2005; 85(1): 585 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Witschi Carcinogenic Activity of Cigarette Smoke Gas Phase and Its Modulation by Beta-Carotene and N-Acetylcysteine Toxicol. Sci., March 1, 2005; 84(1): 81 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Bonner, D. Han, J. Nie, P. Rogerson, J. E. Vena, P. Muti, M. Trevisan, S. B. Edge, and J. L. Freudenheim Breast Cancer Risk and Exposure in Early Life to Polycyclic Aromatic Hydrocarbons Using Total Suspended Particulates as a Proxy Measure Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 53 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yamane, K. Shinmura, N. Sunaga, T. Saitoh, S. Yamaguchi, Y. Shinmura, K. Yoshimura, H. Murakami, Y. Nojima, T. Kohno, et al. Suppressive activities of OGG1 and MYH proteins against G:C to T:A mutations caused by 8-hydroxyguanine but not by benzo[a]pyrene diol epoxide in human cells in vivo Carcinogenesis, June 1, 2003; 24(6): 1031 - 1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chen, N. Nguyen, K. Tamura, M. Karin, and R. H. Tukey The Role of the Ah Receptor and p38 in Benzo[a]pyrene-7,8-dihydrodiol and Benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide-induced Apoptosis J. Biol. Chem., May 23, 2003; 278(21): 19526 - 19533. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Oguri, S. V. Singh, K. Nemoto, and J. S. Lazo The Carcinogen (7R,8S)-Dihydroxy-(9S,10R)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene Induces Cdc25B Expression in Human Bronchial and Lung Cancer Cells Cancer Res., February 15, 2003; 63(4): 771 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. De Flora, R. M. Balansky, F. D'Agostini, A. Izzotti, A. Camoirano, C. Bennicelli, Z. Zhang, Y. Wang, R. A. Lubet, and M. You Molecular Alterations and Lung Tumors in p53 Mutant Mice Exposed to Cigarette Smoke Cancer Res., February 15, 2003; 63(4): 793 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Vernhet, N. Allain, M. Le Vee, F. Morel, A. Guillouzo, and O. Fardel Blockage of Multidrug Resistance-Associated Proteins Potentiates the Inhibitory Effects of Arsenic Trioxide on CYP1A1 Induction by Polycyclic Aromatic Hydrocarbons J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 145 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Davis, S. Bhana, A. J. Shorrocks, and F. L. Martin Oestrogens induce G1 arrest in benzo[a]pyrene-treated MCF-7 breast cells whilst enhancing genotoxicity and clonogenic survival Mutagenesis, September 1, 2002; 17(5): 431 - 438. [Abstract] [Full Text] [PDF] |
||||









